back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,249
+12,500 vol $5.06 each |
92,500 | |
| Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,520,000 vol |
80,000 | |
| Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,744,831 vol |
144,465 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$392,000
+1,600,000 vol $0.245 each |
1,900,000 | |
| Filed 2018-03-05 Tx date 2018-03-05 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-240,000
-300,000 vol $0.80 each |
1,600,000 | |
| Filed 2016-03-22 Tx date 2016-03-21 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,111,698
-370,566 vol $3.00 each |
2,889,296 | |
| Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$53,431
+106,862 vol $0.50 each |
3,259,862 | |
| Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-120,000 vol $0.50 each |
300,000 | |
| Filed 2015-09-01 Tx date 2015-08-31 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-167,200
-22,000 vol $7.60 each |
3,153,000 |